Should continuous infusion of β-lactam antibiotics be the first-line approach?

Journal of Clinical Pharmacy and Therapeutics

Volumn 22, Issue 3, 1997, Pages 159-161

  Ronchera Oms, C L ^a   Gregorio, S ^a   Sanllehi, N ^a  

^a Fundacion Univ San Pablo CEU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE;

ADVERSE DRUG REACTION; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; BACTERICIDAL ACTIVITY; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG POTENCY; DRUG STORAGE; HEALTH CARE COST; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NOTE;

EID: 0031467309     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1997.94675946.x     Document Type: Note

References (22)